glp-1 fatty liver disease and Your Liver: What to Monitor While on Semaglutide or Tirzepatide The Role of GLP1-RAs in

doi: 10.1016/j.brainres.2009.10.076

The common factors among this group include having established strong exercise habits during treatment (particularly resistance training), having completely overhauled eating patterns with a focus on high-protein whole-food diets, gradual tapering rather than abrupt discontinuation, and having lost weight slowly enough for metabolic adaptation to partially recalibrate

Clinical studies have shown that patients can expect significant weight loss (around 5-10% of their body weight) after about 6 months of consistent use, although individual results may vary based on lifestyle factors such as diet and exercise

Results of a consensus conference

CrossRef Zhang L, Chen X, Xu Y, et al